Orgenesis Inc (NASDAQ:ORGS) — Market Cap & Net Worth

$9.83 Million USD · Rank #27098

Market Cap & Net Worth: Orgenesis Inc (ORGS)

Orgenesis Inc (NASDAQ:ORGS) has a market capitalization of $9.83 Million ($9.83 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27098 globally and #5542 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Orgenesis Inc's stock price $1.95 by its total outstanding shares 5171310 (5.17 Million). Review how much debt does Orgenesis Inc carry to assess the company's total debt and financial obligations.

Orgenesis Inc Market Cap History: 2025 to 2025

Orgenesis Inc's market capitalization history from 2025 to 2025. Data shows growth from $10.08 Million to $10.08 Million (0.00% CAGR).

Orgenesis Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Orgenesis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of ORGS by Market Capitalization

Companies near Orgenesis Inc in the global market cap rankings as of June 18, 2026.

Key companies related to Orgenesis Inc by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#222	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$110.45 Billion	$458.99
#444	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$62.63 Billion	$607.93
#549	UCB SA	BR:UCB	$49.68 Billion	€252.40
#573	Argen-X	BR:ARGX	$47.14 Billion	€780.20

Orgenesis Inc Historical Marketcap From 2025 to 2025

Between 2025 and today, Orgenesis Inc's market cap moved from $10.08 Million to $ 10.08 Million, with a yearly change of 0.00%.

Year	Market Cap	Change (%)
2025	$10.08 Million	--

End of Day Market Cap According to Different Sources

On Jun 2nd, 2026 the market cap of Orgenesis Inc was reported to be:

Source	Market Cap
Yahoo Finance	$9.83 Million USD
MoneyControl	$9.83 Million USD
MarketWatch	$9.83 Million USD
marketcap.company	$9.83 Million USD
Reuters	$9.83 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Orgenesis Inc

NASDAQ:ORGS USA Biotechnology

Market Cap

$10.08 Million

Market Cap Rank

#27098 Global

#5542 in USA

Share Price

$1.95

Change (1 day)

+0.00%

52-Week Range

$1.95 - $1.95

All Time High

$2.09